Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies
Hui Yi Chew, Priscila Oliveira de Lima, Jazmina L. G. Cruz, et al.
Cell (2020) Vol. 180, Iss. 5, pp. 895-914.e27
Open Access | Times Cited: 152

Showing 1-25 of 152 citing articles:

Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics
Joshua J. Rennick, Angus P. R. Johnston, Robert G. Parton
Nature Nanotechnology (2021) Vol. 16, Iss. 3, pp. 266-276
Closed Access | Times Cited: 912
HER2-Mediated Internalization of Cytotoxic Agents inERBB2Amplified or Mutant Lung Cancers
Bob T. Li, Flavia Michelini, Sandra Misale, et al.
Cancer Discovery (2020) Vol. 10, Iss. 5, pp. 674-687
Open Access | Times Cited: 222
Chemo-physical Strategies to Advance the in Vivo Functionality of Targeted Nanomedicine: The Next Generation
Junjie Li, Kazunori Kataoka
Journal of the American Chemical Society (2020) Vol. 143, Iss. 2, pp. 538-559
Closed Access | Times Cited: 210
N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer
Yutian Zou, Shaoquan Zheng, Xinhua Xie, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 166
Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders
Nicholas A. Maskalenko, Dmitry Zhigarev, Kerry S. Campbell
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 8, pp. 559-577
Open Access | Times Cited: 147
Trastuzumab Mechanism of Action; 20 Years of Research to Unravel a Dilemma
Hamid Maadi, Mohammad Hasan Soheilifar, Wonshik Choi, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3540-3540
Open Access | Times Cited: 123
Design of biologically active binary protein 2D materials
Ariel J. Ben‐Sasson, Joseph L. Watson, William Sheffler, et al.
Nature (2021) Vol. 589, Iss. 7842, pp. 468-473
Open Access | Times Cited: 118
Endocytosis in cancer and cancer therapy
Blerida Banushi, Shannon R. Joseph, Benedict Lum, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 7, pp. 450-473
Closed Access | Times Cited: 101
Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies
Mariacarmela Santarpía, Andrés Aguilar, Imane Chaib, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1475-1475
Open Access | Times Cited: 90
Molecular mechanism of Fast Endophilin-Mediated Endocytosis
Alessandra Casamento, Emmanuel Boucrot
Biochemical Journal (2020) Vol. 477, Iss. 12, pp. 2327-2345
Open Access | Times Cited: 88
When liposomes met antibodies: Drug delivery and beyond
Jiaxing Di, Fang Xie, Yuhong Xu
Advanced Drug Delivery Reviews (2020) Vol. 154-155, pp. 151-162
Closed Access | Times Cited: 82
How can we use the endocytosis pathways to design nanoparticle drug-delivery vehicles to target cancer cells over healthy cells?
Vu Thanh Cong, Jacinta L. Houng, Maria Kavallaris, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 17, pp. 7531-7559
Open Access | Times Cited: 62
Targeting Epidermal Growth Factor Receptor for Cancer Treatment: Abolishing Both Kinase-Dependent and Kinase-Independent Functions of the Receptor
Yuesheng Zhang
Pharmacological Reviews (2023) Vol. 75, Iss. 6, pp. 1218-1232
Open Access | Times Cited: 33
The Chemical Inhibitors of Endocytosis: From Mechanisms to Potential Clinical Applications
Olga Szewczyk‐Roszczenko, Piotr Roszczenko, Anna Shmakova, et al.
Cells (2023) Vol. 12, Iss. 18, pp. 2312-2312
Open Access | Times Cited: 25
An Indocyanine Green‐Based Nanoprobe for In Vivo Detection of Cellular Senescence
Andrew Baker, Muhamad Hartono, Hui‐Ling Ou, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 25
Open Access | Times Cited: 15
Current landscape and future directions of therapeutic approaches for adenoid cystic carcinoma of the salivary glands (Review)
Katarzyna Stawarz, Monika Durzyńska, A Galazka, et al.
Oncology Letters (2025) Vol. 29, Iss. 3
Open Access | Times Cited: 1
Cancer ATF4-mediated CD58 endocytosis impairs anti-tumor immunity and immunotherapy
Hanyi Zeng, Jiaping Yu, Haijian Wang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Methionine metabolite spermidine inhibits tumor pyroptosis by enhancing MYO6-mediated endocytosis
Jiawei Wu, Cong Ding, Chuqing Zhang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Pain Signaling by GPCRs and RTKs
B. Schmidt, Francesco De Logu, Romina Nassini, et al.
Trends in Pharmacological Sciences (2025)
Closed Access | Times Cited: 1
Tight nanoscale clustering of Fcγ receptors using DNA origami promotes phagocytosis
Nadja Kern, Rui Dong, Shawn M. Douglas, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 46
Role of Clathrin and Dynamin in Clathrin Mediated Endocytosis/Synaptic Vesicle Recycling and Implications in Neurological Diseases
Kate Prichard, Nicholas S. O’Brien, Sari R. Murcia, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 35
Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer
Patrícia M. R. Pereira, Komal Mandleywala, Sébastien Monette, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 29
Trogocytosis of CAR molecule regulates CAR-T cell dysfunction and tumor antigen escape
You Zhai, Yicong Du, LI Guan-zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 21
The Large Action of Chlorpromazine: Translational and Transdisciplinary Considerations in the Face of COVID-19
Émmanuel Stip, Tahir A. Rizvi, Farah Mustafa, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 45
Adenoid cystic carcinoma: a review of clinical features, treatment targets and advances in improving the immune response to monoclonal antibody therapy
James Nightingale, Benedict Lum, Rahul Ladwa, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1875, Iss. 2, pp. 188523-188523
Closed Access | Times Cited: 40
Page 1 - Next Page

Scroll to top